 |
||||||
 |
||||||
|
||||||
 |
||||||
 |
||||||
 |
||||||
 |
||||||
 |
||||||
 |
||||||
 |
||||||
  
|
| The
Morningside Group, established in the USA in 1986, is a global private
investment group owned by the Chan Family of the Public-listed Hang
Lung Group of Hong Kong, China. Through its worldwide investment corporations and in collaboration with other investors, the group has greatly invested in the sunrise industries in the North Americas, the European Continent, the Asia Pacific Region, India and China. The ultimate objective is to establish its leadership in some selected industries. In each its investment, this group is dedicated to long-term investment for the biggest interests. Besides the capital investment, Morningside Group also shares its management experience and global business net with each investment. With the principle of localization, the group takes full use of the outstanding professionals and cooperates with the partners in its invested regions so as to reach the best profit. HCD Holdings Limited has been engaged in marketing and distributing drugs, medical devices, bio-products, diagnostic kits, scientific research instruments and consumables for over 20 years. Now it has sound business relations with more than 30 countries and regions. |
